A 2019 review of tranexamic acid (TXA) in gynecologic surgery notes that the evidence regarding use of TXA in ectopic pregnancy is exclusively from case reports. In one case (see Table 1), a Jehovah’s Witness patient received 1 g intravenous (IV) TXA intraoperatively. Two other cases have observed its use in cervical ectopic pregnancies, where one patient received 1 g IV TXA in conjunction with intramuscular methotrexate and the other one received two doses of 1 g IV TXA 18 hours apart after removal of a double-balloon cervical ripening catheter. The authors emphasized the lack of robust, conclusive evidence supporting use of TXA for this particular indication. [1], [2], [3]